Brazil Synthetic Biology Market Size & Outlook, 2023-2030
Brazil synthetic biology market, 2018-2030 (US$M)
Related Markets
Brazil synthetic biology market highlights
- The Brazil synthetic biology market generated a revenue of USD 214.6 million in 2023 and is expected to reach USD 823.7 million by 2030.
- The Brazil market is expected to grow at a CAGR of 21.2% from 2024 to 2030.
- In terms of segment, pcr technology was the largest revenue generating technology in 2023.
- NGS Technology is the most lucrative technology segment registering the fastest growth during the forecast period.
Synthetic biology market data book summary
| Market revenue in 2023 | USD 214.6 million |
| Market revenue in 2030 | USD 823.7 million |
| Growth rate | 21.2% (CAGR from 2023 to 2030) |
| Largest segment | Pcr technology |
| Fastest growing segment | NGS Technology |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies |
| Key market players worldwide | Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Brazil accounted for 1.5% of the global synthetic biology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil synthetic biology market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 823.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Synthetic Biology Market Scope
Synthetic Biology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Brazil synthetic biology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synthetic biology market will help companies and investors design strategic landscapes.
Pcr technology was the largest segment with a revenue share of 27.4% in 2023. Horizon Databook has segmented the Brazil synthetic biology market based on ngs technology, pcr technology, genome editing technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
In Brazil, the University of SãoPaulo (USP) established USP SynBio center, which is supporting the scientist community in R&D in the country. Synthetic and systems biology center is a part of SãoPaulo State Bioenergy Center.
The objective of this center is to bring researchers from all disciplines of biomechanical engineering, biosciences, chemistry, statistics, and engineering for synthetic biology. In Brazil, one of the fastest applications of synthetic biology is in the area of renewable energy from biofuel and biomass production.
Most of this biofuel is produced from sugarcane in the country. Moreover, the biotechnology industry in Brazil is in the growth phase, and infrastructure and capacity in the country vary from sector to sector.
Reasons to subscribe to Brazil synthetic biology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Brazil synthetic biology market databook
-
Our clientele includes a mix of synthetic biology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Brazil synthetic biology market , including forecasts for subscribers. This country databook contains high-level insights into Brazil synthetic biology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Brazil synthetic biology market size, by technology, 2018-2030 (US$M)
Brazil Synthetic Biology Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
